CAS No.: 1431727-04-6
PLS-123 Catalog No. CSN20637
PLS-123 is a covalent irreversible Btk inhibitor with potential anti-proliferative activity.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 参考文献
- [1] Li J, Wang X, et al. The mTOR kinase inhibitor everolimus synergistically enhances the anti-tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS-123 on Mantle cell lymphoma. Int J Cancer. 2017 Sep 14.
- [2] Ding N, Li X, et al. Irreversible dual inhibitory mode: the novel Btk inhibitor PLS-123 demonstrates promising anti-tumor activity in human B-cell lymphoma. Oncotarget. 2015 Jun 20;6(17):15122-36.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 1431727-04-6 | 储存条件 |
|
|
| 分子式 | C31H26F3N7O4 | 运输 | 蓝冰 | |
| 分子量 | 617.58 | 别名 |
